Klinikum Oldenburg gGmbH

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Chronic lymphocytic leukaemia1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• University of Ulm2 trials
• German CLL Study Group1 trial

Running trials

• Active, not recruiting

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· Phase 3· German CLL Study Group· Source

• Recruiting

  Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project

  NCT01252485· University of Ulm· Source

  Contact: Andreas Voss, Dr.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting

Closed trials

• Completed

  Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

  NCT02013648· Phase 3· University of Ulm· Source